126 related articles for article (PubMed ID: 35215911)
1. Ferristatin II Efficiently Inhibits SARS-CoV-2 Replication in Vero Cells.
Sokolov A; Isakova-Sivak I; Grudinina N; Mezhenskaya D; Litasova E; Kostevich V; Stepanova E; Rak A; Sychev I; Kirik O; Rudenko L
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215911
[TBL] [Abstract][Full Text] [Related]
2. Molecular mimicry of the receptor-binding domain of the SARS-CoV-2 spike protein: from the interaction of spike-specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin.
Sokolov AV; Isakova-Sivak IN; Mezhenskaya DA; Kostevich VA; Gorbunov NP; Elizarova AY; Matyushenko VA; Berson YM; Grudinina NA; Kolmakov NN; Zabrodskaya YA; Komlev AS; Semak IV; Budevich AI; Rudenko LG; Vasilyev VB
Biometals; 2023 Jun; 36(3):437-462. PubMed ID: 36334191
[TBL] [Abstract][Full Text] [Related]
3. Ferristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo.
Byrne SL; Buckett PD; Kim J; Luo F; Sanford J; Chen J; Enns C; Wessling-Resnick M
PLoS One; 2013; 8(7):e70199. PubMed ID: 23894616
[TBL] [Abstract][Full Text] [Related]
4. Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.
Ragotte RJ; Pulido D; Donnellan FR; Hill ML; Gorini G; Davies H; Brun J; McHugh K; King LDW; Skinner K; Miura K; Long CA; Zitzmann N; Draper SJ
mSphere; 2021 Aug; 6(4):e0064721. PubMed ID: 34378982
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of iron uptake by ferristatin II is exerted through internalization of DMT1 at the plasma membrane.
Yanatori I; Yasui Y; Noguchi Y; Kishi F
Cell Biol Int; 2015 Apr; 39(4):427-34. PubMed ID: 25491917
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.
Karthika T; Joseph J; Das VRA; Nair N; Charulekha P; Roji MD; Raj VS
Cells; 2021 Jul; 10(7):. PubMed ID: 34359983
[TBL] [Abstract][Full Text] [Related]
7. Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection
Curreli F; Victor SMB; Ahmed S; Drelich A; Tong X; Tseng CK; Hillyer CD; Debnath AK
mBio; 2020 Dec; 11(6):. PubMed ID: 33310780
[TBL] [Abstract][Full Text] [Related]
8. Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro.
Salas Rojas M; Silva Garcia R; Bini E; Pérez de la Cruz V; León Contreras JC; Hernández Pando R; Bastida Gonzalez F; Davila-Gonzalez E; Orozco Morales M; Gamboa Domínguez A; Sotelo J; Pineda B
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477376
[TBL] [Abstract][Full Text] [Related]
9. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.
Morokutti-Kurz M; Fröba M; Graf P; Große M; Grassauer A; Auth J; Schubert U; Prieschl-Grassauer E
PLoS One; 2021; 16(2):e0237480. PubMed ID: 33596218
[TBL] [Abstract][Full Text] [Related]
10. Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
Liu Z; Zheng H; Lin H; Li M; Yuan R; Peng J; Xiong Q; Sun J; Li B; Wu J; Yi L; Peng X; Zhang H; Zhang W; Hulswit RJG; Loman N; Rambaut A; Ke C; Bowden TA; Pybus OG; Lu J
J Virol; 2020 Aug; 94(17):. PubMed ID: 32571797
[TBL] [Abstract][Full Text] [Related]
11. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
[TBL] [Abstract][Full Text] [Related]
12. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.
Puray-Chavez M; LaPak KM; Schrank TP; Elliott JL; Bhatt DP; Agajanian MJ; Jasuja R; Lawson DQ; Davis K; Rothlauf PW; Liu Z; Jo H; Lee N; Tenneti K; Eschbach JE; Shema Mugisha C; Cousins EM; Cloer EW; Vuong HR; VanBlargan LA; Bailey AL; Gilchuk P; Crowe JE; Diamond MS; Hayes DN; Whelan SPJ; Horani A; Brody SL; Goldfarb D; Major MB; Kutluay SB
Cell Rep; 2021 Jul; 36(2):109364. PubMed ID: 34214467
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
[TBL] [Abstract][Full Text] [Related]
14. A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples.
Madan T; Biswas B; Varghese PM; Subedi R; Pandit H; Idicula-Thomas S; Kundu I; Rooge S; Agarwal R; Tripathi DM; Kaur S; Gupta E; Gupta SK; Kishore U
Am J Respir Cell Mol Biol; 2021 Jul; 65(1):41-53. PubMed ID: 33784482
[TBL] [Abstract][Full Text] [Related]
15. The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry.
Zhang J; Huang F; Xia B; Yuan Y; Yu F; Wang G; Chen Q; Wang Q; Li Y; Li R; Song Z; Pan T; Chen J; Lu G; Zhang H
Signal Transduct Target Ther; 2021 May; 6(1):189. PubMed ID: 33980808
[TBL] [Abstract][Full Text] [Related]
16. Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity.
Diomede L; Baroni S; De Luigi A; Piotti A; Lucchetti J; Fracasso C; Russo L; Bonaldo V; Panini N; Filippini F; Fiordaliso F; Corbelli A; Beeg M; Pizzato M; Caccuri F; Gobbi M; Biasini E; Caruso A; Salmona M
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578326
[TBL] [Abstract][Full Text] [Related]
17. Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.
Wang X; Wen Z; Cao H; Luo J; Shuai L; Wang C; Ge J; Wang X; Bu Z; Wang J
J Virol; 2023 Feb; 97(2):e0161122. PubMed ID: 36779763
[TBL] [Abstract][Full Text] [Related]
18. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
[TBL] [Abstract][Full Text] [Related]
19. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
[TBL] [Abstract][Full Text] [Related]
20. The
Urda L; Kreuter MH; Drewe J; Boonen G; Butterweck V; Klimkait T
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
